Questions regarding insurance?Not sure what to bring for your visit?Need to fill out patient forms?
View Patient Information
Connect with the INIM
Ft. Lauderdale-Davie Center for Collaborative Research, 4th Floor 3301 College Avenue Fort Lauderdale, FL 33314 Directions
Kendall Kendall Village Center Professional Arts Bldg., Suite 111 8501 SW 124th Avenue Miami, FL 33183 Directions
Schedule an Appointment
Call us today to set up an appointment:
Phone Number: (954) 262-2850
Office Hours: Mon-Fri: 9 am - 5 pm
Director, Institute for Neuro-Immune Medicine, Nova Southeastern University
Director, Clinical Immunology Research, Miami VAMC
Professor of Medicine, Department of Clinical Immunology, College of Osteopathic Medicine, Nova Southeastern University
Chair, Department of Clinical Immunology, College of Osteopathic Medicine, Nova Southeastern University
Professor Emerita, University of Miami, School of Medicine
Nancy Klimas, MD, has more than 30 years of professional experience and has achieved international recognition for her research and clinical efforts in multi-symptom disorders, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Gulf War Illness (GWI), fibromyalgia and other neuro-immune disorders. She is immediate past president of the International Association for CFS and ME (IACFS/ME), a professional organization of clinicians and investigators, and is also a member of the VA Research Advisory Committee for GWI, the NIH P2P CFS Committee, and the Institute of Medicine ME/CFS Review Panel. Dr. Klimas has advised three Secretaries of Health and Human Services, including Kathleen Sabelius, during her repeated service on the Health and Human Services CFS advisory committee. Dr. Klimas has been featured on Good Morning America, in USA Today and the New York Times.
NIH R15: Genomic approach to find novel biomarkers and mechanisms of CFS/ME The employment of advanced genomic technologies and a well-rounded research approach will allow us to identify regulators of transcription that result in characteristic symptomatology associated with CFS/ME in female patients.
DoD GWIRP/ IIREA:Testing the Model: A Phase I/II Randomized Double Blind Placebo Control Trial of Therapeutics: Liposomal Glutathione and Curcumin The goal is to implement a phase I/II placebo control double blinded 3 arm study of liposomal glutathione, curcumin and placebo in GWI in 75 veterans with GWI (25 per arm) and assess the safety, feasibility and clinical response to the interventions;. Integrate repeat assessment and modeling of dynamic response to exercise challenge in order to map homeostatic pathways before and after 12 weeks of intervention. Finally, assess antioxidant and methylation-related metabolic status prior to, during, and after acute exercise in GWI subjects before and after these antioxidant interventions.